ong-term stability of Clareon intraocular lens

Not Applicable

• Conditions: Senile ( age related ) cataract; Ocular disease

• Registration Number: JPRN-jRCTs032190093
• Lead Sponsor: Miyata Akira

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-09-10
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Patients who meet all of the following criteria are included in this study
1) Patients scheduled for cataract surgery by phacoemulsification due to age related cataract
2) Patients in whom the intraocular lens is expected to be able to be inserted and fixed in crystalline lens capsule
3) Patients in whom the calculated lens power is within available range
4) Patients who do not have other eye diseases than cataract which affect postoperative outcomes
5) Patients in whom postoperative corrected visual acuities are expected to be 0.8 or higher
6) Patients who can be followed up after the operation
7) Patients aged 20 years or elder at giving their consent
8) Patients who can understand the content of informed consent documents and can provide written consent form
9) Male and female

Exclusion Criteria

Patients who fall into any of the following criteria are excluded from participating in the study.
1) Patients with eye diseases such as uncontrolled glaucoma,
progressive diabetic retinopathy, uveitis, retinal detachment, iris neovascularization, corneal degeneration, or patients with history of corneal surgery
2) Patients with eye diseases that may influence postoperative visual acuity, or p atients using medicines that may influence visual acuity
3) Patients who plan secondary implantation of intraocular lens
4) Patients who would require comp licated surgery due to zonular rupture, posterior capsule rapture, vitreous prolapse, hyphema, incompletion of in the bag implantation, etc.
5) Patients who have risks of serious postoperative complications
6) Patients with other physical body or ophthalmic dise ases considered unsuitable for participating in the study by an investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified